Finance

Lists
Why is 605507 down 2,22%?
Dive Deeper
605507:SHA
Guobang Pharma Ltd
15,84 CNY
-2,22%
(-0,36) 1D
16 ოქტ, 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 605507...
Open
16,29 CNY
High
16,54 CNY
Low
15,71 CNY
Mkt. cap
12,39 მლრდ.
Avg. vol.
8,69 მლნ.
Volume
6,50 მლნ.
Dividend
2,71%
Quarterly dividend
0,11 CNY
Ex-dividend date
29 მაი. 2026
P/E ratio
17,41
52-wk high
21,41 CNY
52-wk low
14,34 CNY
EPS
0,91 CNY
No. of employees
4 ათ.
Open
16,29 CNY
High
16,54 CNY
Low
15,71 CNY
Mkt. cap
12,39 მლრდ.
Avg. vol.
8,69 მლნ.
Volume
6,50 მლნ.
Dividend
2,71%
Quarterly dividend
0,11 CNY
Ex-dividend date
29 მაი. 2026
P/E ratio
17,41
52-wk high
21,41 CNY
52-wk low
14,34 CNY
EPS
0,91 CNY
No. of employees
4 ათ.
News stories
From web sources and news partners
Opening Bell Daily
Opening Bell Daily
·
43 წუთის წინ
Stock market after midterms: S&P 500 up all 19 times
Simply Wall Street
Simply Wall Street
·
1 საათის წინ
Aura Minerals (NasdaqGS:AUGO) Shares Just Moved, So What Is Going On?
About Guobang Pharma Ltd
CEO-
Employees4,25 ათ.
Founded29 მარ. 1996
Headquarters-
SectorPharmaceutical industry
Websitegbgcn.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,44 მლრდ.
1,54 მლრდ.
1,52 მლრდ.
1,62 მლრდ.
Cost of goods sold
1,04 მლრდ.
1,22 მლრდ.
1,17 მლრდ.
1,23 მლრდ.
Cost of revenue
1,04 მლრდ.
1,22 მლრდ.
1,17 მლრდ.
1,23 მლრდ.
Research and development expenses
56,01 მლნ.
56,39 მლნ.
29,72 მლნ.
68,59 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
95,62 მლნ.
91,84 მლნ.
97,88 მლნ.
102,20 მლნ.
Operating expense
147,58 მლნ.
163,74 მლნ.
144,00 მლნ.
181,88 მლნ.
Total operating expenses
1,19 მლრდ.
1,38 მლრდ.
1,31 მლრდ.
1,42 მლრდ.
Operating income
251,14 მლნ.
162,24 მლნ.
206,77 მლნ.
205,09 მლნ.
Other non operating income
-6,09 მლნ.
4,26 მლნ.
-17,56 მლნ.
15,56 მლნ.
EBT including unusual items
253,57 მლნ.
176,38 მლნ.
187,17 მლნ.
200,66 მლნ.
EBT excluding unusual items
249,16 მლნ.
157,04 მლნ.
186,75 მლნ.
187,38 მლნ.
Income tax expense
39,67 მლნ.
26,70 მლნ.
27,04 მლნ.
19,47 მლნ.
Effective tax rate
15,65%
15,14%
14,45%
9,70%
Other operating expenses
-3,71 მლნ.
17,40 მლნ.
6,70 მლნ.
16,35 მლნ.
Net income
214,67 მლნ.
150,58 მლნ.
160,63 მლნ.
180,72 მლნ.
Net profit margin
14,87%
9,77%
10,56%
11,14%
Earnings per share
-
-
-
-
Interest and investment income
12,79 მლნ.
6,57 მლნ.
6,74 მლნ.
4,95 მლნ.
Interest expense
-5,20 მლნ.
-6,86 მლნ.
-9,19 მლნ.
-1,98 მლნ.
Net interest expenses
7,59 მლნ.
-292,84 ათ.
-2,45 მლნ.
2,97 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
359,34 მლნ.
281,48 მლნ.
326,01 მლნ.
328,14 მლნ.
Gain or loss from assets sale
-453,56 ათ.
-24,81 მლნ.
-
-
AI content may include mistakes. Learn more
Google აპები